Cargando…
Clinical trials, progression-speed differentiating features and swiftness rule of the innovative targets of first-in-class drugs
Drugs produce their therapeutic effects by modulating specific targets, and there are 89 innovative targets of first-in-class drugs approved in 2004–17, each with information about drug clinical trial dated back to 1984. Analysis of the clinical trial timelines of these targets may reveal the trial-...
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299286/ https://www.ncbi.nlm.nih.gov/pubmed/30689717 http://dx.doi.org/10.1093/bib/bby130 |